MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The effectiveness of deep brain stimulation on dystonia: A meta-analysis

A.K.D. Antonio, E.A. Barcelon, P.M.D. Pasco (Manila, Philippines)

Meeting: 2016 International Congress

Abstract Number: 1661

Keywords: Deep brain stimulation (DBS), Dystonia: Treatment

Session Information

Date: Thursday, June 23, 2016

Session Title: Dystonia

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To summarize, assess and perform a quantitative analysis of the available evidence on the effectiveness and safety of deep brain stimulation on improving dystonia severity and its impact on the quality of life of patients with medically refractory dystonia.

Background: Dystonia is a genetically associated hyperkinetic movement disorder characterized by abnormal often, twisting movements and sustained postures from co-contraction of antagonistic muscles. It results in significant disability in at least 0.01-0.02% of the general population. Deep brain stimulation have shown promising utility in the treatment of dystonia.

Methods: Literature search was made using the key words “deep brain stimulation” and “dystonia” on several online databases. Randomized controlled trials on the effectiveness of deep brain stimulation on dystonia were selected and appraised. Quantitative analysis was done with disease severity in the form of the clinical global impression score as the primary outcome. The impact on quality of life was analyzed through the eight domains of the SF-36 questionnaire and the adverse effects of the intervention were tabulated.

Results: The studies showed a significant decrease in dystonia severity at three months of pallidal neurostimulation by both patient (-2.89 [-3.71, -2.07], I2 = 51%, P for heterogeneity = 0.15, p-value < 0.00001) and physician (-2.71 [-3.25, -2.16], I2 = 48%, P for heterogeneity = 0.17, p-value < 0.00001) ratings. Significant improvement in quality of life was seen on the physical function (9.97 [1.19, 18.75], I2 = 80%, P for heterogeneity=0.03, p-value=0.03), general health (9.29 [2.65, 15.94], I2 = 29%, P for heterogeneity = 0.24, p-value=0.006) and vitality (6.77 [0.04, 13.50], I2 = 33%, P for heterogeneity = 0.22, p-value=0.05) domains. Common adverse effects are device infection and dysarthria.

Conclusions: Deep brain stimulation is effective in reducing disease severity in medically refractory dystonia. It has some positive impact on the physical function, general health and vitality of patients. It should be offered as a treatment option for cases of medically-refractory dystonia.

To cite this abstract in AMA style:

A.K.D. Antonio, E.A. Barcelon, P.M.D. Pasco. The effectiveness of deep brain stimulation on dystonia: A meta-analysis [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/the-effectiveness-of-deep-brain-stimulation-on-dystonia-a-meta-analysis/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-effectiveness-of-deep-brain-stimulation-on-dystonia-a-meta-analysis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley